No-preparation Resin Bonded Bridges for the Replacement of Single Missing Teeth

August 16, 2020 updated by: Dr Michael G. Botelho, The University of Hong Kong

Tooth replacement is a significant issue in the World. Such replacement is considered important by patients to improve aesthetics, function and quality of life. Tooth replacement is therefore a significant issue. Resin-bonded bridges (RBBs) are conservative and cost-effective tooth replacement option that involves minimal tooth preparation and are secured in place with an adhesive cement by bonding to the outer enamel layer of the tooth. Clinical reports of these prostheses at the University of Hong Kong shows some of the highest success rate and greatest longevity in the dental literature. However, a problem with this type of prosthesis in that it still needs some tooth preparation to accommodate the framework thickness of the bridge. In some patients with tooth wear, this may mean cutting through the enamel crown down into dentine which will weaken the tooth. In light of the tooth preparation some patients will refuse this treatment, in particular patients with dental drill phobias.

The aim of this study is to investigate RBBs with tooth preparation and with no tooth preparation for the replacement of single missing teeth in a randomized controlled trial. However, a significant consequence of a no preparation RBB will mean that after cementation the prosthesis will interfere with the patient's bite, making the bridge prosthesis stand high. This will take time for the patient's original occlusion to re-establish itself by the movement of the tooth supporting the bridge. Despite the success of "supra-occluding" restoration has been reported in some studies, currently neither no preparation nor supraoccluding dental bridges are the standard of care for general dental practitioners and have not been reported on as a clinical trial in the literature. Most symptoms reported for supraoccluding restorations were transient and are reversible. The findings of this research will have significant impact on the teaching and practice for clinical prosthodontics and patient care worldwide. Patients will have a dental prosthesis that requires no dental drilling, no local anaesthetic and will have a stronger tooth supporting the bridge that should have greater longevity. More patients, in particular phobic patients will therefore seek treatment for tooth replacement with this conservative treatment option.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, China
        • Prosthodontics, Faculty of Dentistry, The University of Hong Kong
        • Contact:
        • Contact:
        • Principal Investigator:
          • Michael G Botelho, BDS MSc PhD
        • Sub-Investigator:
          • Walter Y. H. Lam, BDS MDS AdvDipProsth
        • Sub-Investigator:
          • Edward C. M. Lo, BDS MDS PhD
        • Sub-Investigator:
          • Henry W. K. Luk, PhD
        • Sub-Investigator:
          • Yanqi Yang, BDS, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. 15+ years old
  2. A complete bite on the supporting abutment tooth
  3. At least one missing upper incisor
  4. Controlled dental disease - no active caries or periodontal diseases
  5. A minimum of 12 occluding pairs of natural teeth
  6. Patients will be available to be clinically reviewed up to 3 years

Exclusion Criteria:

  1. Patients with uncontrolled active tooth decay or periodontal disease (i.e. 5+ mm probing depth and bleeding on probing).
  2. Patients with teeth missing opposite to the planned RBB
  3. Abutment tooth mobility of 2 or greater (Millers classification)
  4. Patients with debilitating illnesses or complicating medical conditions
  5. Heavily restored tooth abutment not suitable for an RBB
  6. A supporting abutment with an open bite

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: No preparation resin bonded bridges
RBBs with no or minimal preparation of their abutment teeth
Placement of resin bonded bridges on teeth with no or minimal cutting of their supporting teeth
Active Comparator: Routine resin bonded bridges
RBBs with routine tooth preparation of their abutment teeth
Placement of resin bonded bridges on teeth after routine cutting of their supporting teeth

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prosthesis (resin bonded bridge RBB) retention/survival
Time Frame: 12 months
Presence of the prosthesis in patient's mouth (Yes/No) by clinical visual examination
12 months
Prosthesis (resin bonded bridge RBB) retention/survival
Time Frame: 24 months
Presence of the prosthesis in patient's mouth (Yes/No) by clinical visual examination
24 months
Prosthesis (resin bonded bridge RBB) retention/survival
Time Frame: 36 months
Presence of the prosthesis in patient's mouth (Yes/No) by clinical visual examination
36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse events that related to no preparation/supra-occluding treatment approach
Time Frame: Up to 36 months
Presence of clinical signs and symptoms or not (Yes/No) including but not limited to impact on patient's speech as well as thermal sensitivity, increased tooth mobility, periodontal/pulpal health of the abutment teeth
Up to 36 months
Time taken to re-establish the occlusion
Time Frame: Up to 36 months
Settling of occlusion is judged by shimstock/occlusal marking paper on teeth adjacent to the prosthesis
Up to 36 months
Patient centered outcomes to the Prosthesis (I)
Time Frame: 36 months
Subject's satisfaction (in visual analogue scale) on the RBB
36 months
Patient centered outcomes to the Prosthesis (II)
Time Frame: 36 months
Impact of RBB on subject's oral health related quality of life (Oral Health Impact Profile, OHIP, in Likert scale)
36 months
Patient centered outcomes to the no preparation/supra-occluding treatment approach (I)
Time Frame: Up to 12 months
Subject's satisfaction (in visual analogue scale) related to the no preparation/supraoccluding treatment approach RBBs
Up to 12 months
Patient centered outcomes to the no preparation/supra-occluding treatment approach (II)
Time Frame: Up to 12 months
Impact of the no preparation/supraoccluding treatment approach on subject's oral health related quality of life (Oral Health Impact Profile, OHIP, in Likert scale)
Up to 12 months
Biomedical mediators of the no preparation/supra-occluding abutment teeth (I)
Time Frame: Up to 36 months
Prostaglandin E2 level (pg/ul) in the gingival crevicular fluid of abutment teeth
Up to 36 months
Biomedical mediators of the contralateral control teeth (I)
Time Frame: Up to 36 months
Prostaglandin E2 level (pg/ul) in the gingival crevicular fluid of contralateral control teeth
Up to 36 months
Biomedical mediators of the no preparation/supra-occluding abutment teeth (II)
Time Frame: Up to 36 months
Human Interleukin-1 Family 2 level (pg/ul) in the gingival crevicular fluid of abutment teeth
Up to 36 months
Biomedical mediators of the contralateral control teeth (II)
Time Frame: Up to 36 months
Human Interleukin-1 Family 2 level (pg/ul) in the gingival crevicular fluid of contralateral control teeth
Up to 36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 1, 2021

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

December 30, 2016

First Submitted That Met QC Criteria

January 19, 2017

First Posted (Estimate)

January 24, 2017

Study Record Updates

Last Update Posted (Actual)

August 18, 2020

Last Update Submitted That Met QC Criteria

August 16, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Missing Teeth

Clinical Trials on RBBs with no or minimal preparation of their abutment teeth

Subscribe